Product Description:
Ondansetron is a selective serotonin 5-HT3 receptor antagonist used to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, and surgery. It works by blocking the action of serotonin, a natural substance that may cause vomiting.
Presentations:
Strength: 8 mg
Dosage Form: Film-coated tablets
Packaging Options:
Blister packs of 10, 30, or 100 tablets
Bulk packs for hospital or institutional supply (subject to availability)
Indications:
Prevention of nausea and vomiting associated with highly or moderately emetogenic chemotherapy
Prevention of nausea and vomiting due to radiation therapy
Prevention and treatment of post-operative nausea and vomiting (PONV)
Common Use Cases:
Oncology clinics administering cisplatin or other emetogenic regimens
Post-surgical units for anesthesia-related nausea
Outpatient departments administering radiotherapy
Administration & Dosage:
Typically administered one to two hours prior to chemotherapy or surgery, followed by maintenance doses as needed.
Adult dose: 8 mg orally, frequency depending on clinical protocol or physician guidance.
Regulatory Status:
Listed in WHO Model List of Essential Medicines
Available as generic and branded formulations
Manufactured in GMP-certified facilities
NDC codes and Certificates of Analysis (COA) available upon request
Important Notes:
Store below 30°C in a dry place
For wholesale export only; not for direct patient dispensing
Spanish-language labeling and Cofepris-compliant registration services available upon request